BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs6983267
,
BRAF
,
Coagulation
,
Breast Cancer
,
Pancreas
,
Avian flu virus
,
Tamoxifen
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
domain- peptide
Summary
General Info
Curated Studies
Most Correlated Studies
T cell acute lymphoblastic leukemia cell lines treated with Nemo-binding domain peptide
L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
Protein domains of low sequence complexity-dark matter of the proteome.
E2EDA: Protein Domain Assembly Based on End-to-End Deep Learning.
Sortase-Catalyzed Protein Domain Inversion.
LIM domain proteins.
InParanoiDB 9: Ortholog Groups for Protein Domains and Full-Length Proteins.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Phase II Trial to Correlate Radiographic Response Induced By Gefitinib With Mutations in the Protein…
Vaccine Therapy in Treating Patients Receiving Trastuzumab For HER2-Positive Stage IIIB-IV Breast Ca…
A Phase I Safety and Immunogenicity Trial of UBI Multivalent HIV-1 Peptide Immunogen in HIV-1 Serone…
A Multi-domain Lifestyle Intervention Among Aged Community-residents in Zhejiang, China
Immunization of Disease-Free Melanoma Patients With Different HLA-A2 Peptides
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ